enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Aducanumab - Wikipedia

   en.wikipedia.org/wiki/Aducanumab

   On 22 October 2019, Biogen announced that it would be restarting the FDA approval process for aducanumab stating that analysis of a larger dataset from its Phase 3 trials [33] [34] [35] showed that the drug reduced clinical decline in patients with early Alzheimer's disease when given at higher doses. [36]

3. How a new FDA-approved drug can — and can’t - AOL

   www.aol.com/fda-approved-drug-t-help-121600044.html

   In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...

4. EXPLAINER-What does FDA approval of Biogen's Alzheimer's drug ...

   www.aol.com/news/explainer-does-fda-approval...

   The U.S. Food and Drug Administration has approved Biogen's aducanumab, the first drug to target an underlying cause of Alzheimer's disease. The drug, to be sold under the brand Aduhelm, is the ...

5. Alzheimer's: Are newly approved drugs making a real-life ...

   www.aol.com/alzheimers-newly-approved-drugs...

   After a lull of nearly 2 decades, the Food and Drug Administration (FDA) has approved some novel drugs for the treatment of Alzheimer’s disease since 2021.

6. US FDA grants standard approval of Eisai/Biogen Alzheimer's drug

   www.aol.com/news/us-fda-grants-standard-approval...

   LOS ANGELES (Reuters) -Eisai and Biogen's Leqembi won a coveted standard approval nod from the U.S. Food and Drug Administration on Thursday, the first Alzheimer's treatment to achieve that goal ...

7. Biogen - Wikipedia

   en.wikipedia.org/wiki/Biogen

   However, an advisory panel for the FDA voted against approval of this drug. [95] On June 7, 2021, the FDA granted approval of Aducanumab for the treatment of Alzheimer's disease. Aducanumab was approved using the accelerated approval pathway, and Biogen will be required to conduct a post-approval clinical trial to verify clinical benefit for ...